Cas:14246-21-0 dl-valine-2-d1 manufacturer & supplier

Chemical Name:dl-valine-2-d1

CAS.NO:14246-21-0

Synonyms:Glucosamineoximehydrochlorid;D-Glucosamine-oximeHCI;D-Glucosamine-oxime hydrochlorid;D-Glucosamine-oximeHCl;2-amino-2-deoxy-d-glucose oxime,hydrochloride;2-Amino-2-desoxy-d-glucose-oxim,Hydrochlorid;2-amino-2-deuterio-3-methyl-butyric acid

Molecular Formula:C₅H₁₀DNO₂

Molecular Weight:118.15300

HS Code:

Physical and Chemical Properties:

Melting point:295ºC (subl.)(lit.)

Boiling point:213.642ºC at 760 mmHg

Density:1.073 g/cm3

Index of Refraction:

PSA:63.32000

Exact Mass:118.08500

LogP:0.75460

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Glucosamineoximehydrochlorid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-amino-2-deuterio-3-methyl-butyric acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,D-Glucosamine-oxime hydrochlorid Use and application,2-amino-2-deuterio-3-methyl-butyric acid technical grade,usp/ep/jp grade.

Related News: The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. dl-valine-2-d1 manufacturer Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. dl-valine-2-d1 supplier The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term. dl-valine-2-d1 vendor The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term. dl-valine-2-d1 factory The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.